Analysis of Low-Frequency Mutations Associated with Drug Resistance to Raltegravir before Antiretroviral Treatment

Raltegravir is highly efficacious in the treatment of HIV-1 infection. The prevalence and impact on virologic outcome of low-frequency resistant mutations among HIV-1-infected patients not previously treated with raltegravir have not been fully established. Samples from HIV treatment-experienced pat...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Liu, Jia, Miller, Michael D., Danovich, Robert M., Vandergrift, Nathan, Cai, Fangping, Hicks, Charles B., Hazuda, Daria J., Gao, Feng
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology (ASM) 2011
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3067114/
https://ncbi.nlm.nih.gov/pubmed/21173185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01492-10
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky